Szymon Janczar

560 total citations
29 papers, 338 citations indexed

About

Szymon Janczar is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Szymon Janczar has authored 29 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Genetics and 8 papers in Oncology. Recurrent topics in Szymon Janczar's work include Blood disorders and treatments (7 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Genetics and Neurodevelopmental Disorders (5 papers). Szymon Janczar is often cited by papers focused on Blood disorders and treatments (7 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Genetics and Neurodevelopmental Disorders (5 papers). Szymon Janczar collaborates with scholars based in Poland, United Kingdom and United States. Szymon Janczar's co-authors include Adam J.W. Paige, Wojciech Młynarski, Hani Gabra, Beata Zalewska‐Szewczyk, Mingjun Sun, Karen J. Taylor, John F. Smyth, Charlie Gourley, David J. Harrison and Jieqing Zhang and has published in prestigious journals such as Blood, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Szymon Janczar

24 papers receiving 335 citations

Peers

Countries citing papers authored by Szymon Janczar

Since Specialization

Citations

This map shows the geographic impact of Szymon Janczar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Szymon Janczar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Szymon Janczar more than expected).

Fields of papers citing papers by Szymon Janczar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Szymon Janczar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Szymon Janczar. The network helps show where Szymon Janczar may publish in the future.

Co-authorship network of co-authors of Szymon Janczar

This figure shows the co-authorship network connecting the top 25 collaborators of Szymon Janczar. A scholar is included among the top collaborators of Szymon Janczar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Szymon Janczar. Szymon Janczar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The genetic landscape of congenital neutropenia in Poland: summary of the nationwide screening campaign 2025 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), Szymon Janczar, Joanna Madzio, (unknown), Sylwia Kołtan, (unknown), Joanna Renke, (unknown), (unknown), Wojciech Młynarski	0
2	A high prevalence of neutrophil‐specific antibodies in ELANE‐mutated severe congenital neutropenia 2023 ·Pediatric Blood & Cancer ·(unknown), Joanna Madzio, (unknown), (unknown), (unknown), Katarzyna Guz, Agnieszka Orzińska, Małgorzata Uhrynowska, (unknown), (unknown), Wojciech Młynarski, Szymon Janczar	7
3	Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland: A 2022 Survey 2023 ·Children ·(unknown), Agata Pastorczak, (unknown), Walentyna Balwierz, (unknown), Jacek Wachowiak, Katarzyna Derwich, (unknown), Krzysztof Kałwak, (unknown), Paweł Łaguna, Iwona Malinowska, (unknown), Jolanta Goździk, (unknown), (unknown), (unknown), Tomasz Szczepański, Wojciech Młynarski, Szymon Janczar	3
4	Four Decades of Carrier Detection and Prenatal Diagnosis in Hemophilia A: Historical Overview, State of the Art and Future Directions 2023 ·International Journal of Molecular Sciences ·Rima Dardik, Szymon Janczar, Shadan Lalezari, Einat Avishai, Sarina Levy‐Mendelovich, Assaf Arie Barg, U. Martinowitz, (unknown), Wojciech Młynarski, Gili Kenet	4
5	Congenital neutropenia: From lab bench to clinic bedside and back 2023 ·Mutation Research/Reviews in Mutation Research ·(unknown), (unknown), (unknown), Szymon Janczar, Wojciech Młynarski	3
6	Isolated central nervous system relapses in patients with high-risk neuroblastoma -clinical presentation and prognosis: experience of the Polish Paediatric Solid Tumours Study Group 2022 ·BMC Cancer ·Aleksandra Wieczorek, Joanna Stefanowicz, (unknown), (unknown), (unknown), Bożenna Dembowska–Bagińska, (unknown), (unknown), Julia Geisler, Tomasz Szczepański, Szymon Skoczeń, Marek Ussowicz, Monika Pogorzała, Szymon Janczar, Walentyna Balwierz	5
7	Severe, Reversible Acute Lung Injury During Autologous Hematopoietic Stem Cell Mobilization After Filgrastim in a Child With Neuroblastoma: A Case Report 2020 ·Transplantation Proceedings ·(unknown), (unknown), (unknown), (unknown), Joanna Bladowska, Szymon Janczar, Marek Ussowicz	2
8	Six molecular patterns leading to hemophilia A phenotype in 18 females from Poland 2020 ·Thrombosis Research ·Szymon Janczar, (unknown), (unknown), (unknown), Anna Klukowska, Paweł Łaguna, Jerzy Windyga, (unknown), (unknown), Teresa Iwaniec, Andrzej Kołtan, (unknown), (unknown), Karolina Janczar, Tomasz Szczepański, (unknown), Walentyna Balwierz, Jacek Treliński, Wojciech Młynarski	8
9	Vaccination in children with chronic severe neutropenia – review of recommendations and a practical approach 2020 ·Central European Journal of Immunology ·Szymon Janczar, Beata Zalewska‐Szewczyk, (unknown), (unknown), Krzysztof Zeman, Wojciech Młynarski	0
10	Unfavorable Outcome of Neuroblastoma in Patients With 2p Gain 2019 ·Frontiers in Oncology ·Katarzyna Szewczyk, Aleksandra Wieczorek, Wojciech Młynarski, Szymon Janczar, (unknown), (unknown), Radosław Chaber, Mariusz Wysocki, Monika Pogorzała, Mirosław Bik-Multanowski, Walentyna Balwierz	14
11	Dynamic changes in specific anti-L-asparaginase antibodies generation during acute lymphoblastic leukemia treatment 2018 ·Pharmacological Reports ·(unknown), Krystyna Wyka, Szymon Janczar, Wojciech Młynarski, Beata Zalewska‐Szewczyk	5
12	Uncommon reasons of the digestive tract-related paraneoplastic syndromes in children with neuroblastic tumors: three case reports 2018 ·Współczesna Onkologia ·Elżbieta Czkwianianc, Beata Zalewska‐Szewczyk, Józef Kobos, (unknown), Szymon Janczar, (unknown), (unknown), Wojciech Młynarski	4
13	WWOX sensitises ovarian cancer cells to paclitaxel via modulation of the ER stress response 2017 ·Cell Death and Disease ·Szymon Janczar, Jaya Nautiyal, Yi Xiao, Edward Curry, Mingjun Sun, (unknown), Adam J.W. Paige, Hani Gabra	23
14	The Role of Histone Protein Modifications and Mutations in Histone Modifiers in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia 2017 ·Cancers ·Szymon Janczar, Karolina Janczar, Agata Pastorczak, Hani Harb, Adam J.W. Paige, Beata Zalewska‐Szewczyk, Marian Danilewicz, Wojciech Młynarski	22
15	Preserved global histone H4 acetylation linked to ETV6-RUNX1 fusion and PAX5 deletions is associated with favorable outcome in pediatric B-cell progenitor acute lymphoblastic leukemia 2015 ·Leukemia Research ·Karolina Janczar, Szymon Janczar, Agata Pastorczak, (unknown), Adam J.W. Paige, Beata Zalewska‐Szewczyk, Małgorzata Wągrowska‐Danilewicz, Marian Danilewicz, Wojciech Młynarski	11
16	Haemophilia A and cardiovascular morbidity in a female SHAM syndrome carrier due to skewed X chromosome inactivation 2015 ·European Journal of Medical Genetics ·Szymon Janczar, Joanna Kosińska, Rafał Płoski, Agata Pastorczak, (unknown), Beata Zalewska‐Szewczyk, Adam J.W. Paige, Maciej Borowiec, Wojciech Młynarski	12
17	The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer 2012 ·Cancer Discovery ·Arthur B. McKie, Sebastian Vaughan, (unknown), Imoh S. Okon, (unknown), (unknown), Mark I. Greene, Qiang Wang, Roshan Agarwal, Dmitry Shaposhnikov, Joshua L. C. Wong, (unknown), Szymon Janczar, Mona El‐Bahrawy, Eric W.‐F. Lam, Naomi E. Chayen, Hani Gabra	41
18	WWOX tumour suppressor gene polymorphisms and ovarian cancer pathology and prognosis 2010 ·European Journal of Cancer ·Adam J.W. Paige, Manuela Zucknick, Szymon Janczar, James Paul, Charles A. Mein, Karen J. Taylor, Moira Stewart, Charlie Gourley, Sylvia Richardson, Timothy Perren, Trivadi S. Ganesan, John F. Smyth, Robert Brown, Hani Gabra	24
19	WWOX Gene Expression Abolishes Ovarian Cancer Tumorigenicity In vivo and Decreases Attachment to Fibronectin via Integrin α3 2009 ·Cancer Research ·Charlie Gourley, Adam J.W. Paige, Karen J. Taylor, (unknown), (unknown), Jieqing Zhang, Mingjun Sun, Szymon Janczar, David J. Harrison, Morwenna Muir, John F. Smyth, Hani Gabra	84
20	Targeting locoregional peritoneal dissemination in ovarian cancer 2009 ·Expert Review of Obstetrics & Gynecology ·Szymon Janczar, John D. Graham, Adam J.W. Paige, Hani Gabra	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact